title: [Effect of an integrative medical regimen on levels of vascular endothelial function and hypersensitive C-reactive protein in elderly patients with isolated systolic hypertension].
abstract: OBJECTIVE
  To observe the effect of a integrative medical regimen (IMR), i.e. combined use of Jiangya Capsule (JYC) and Nimodipine (ND), on blood pressure, TCM clinical symptoms, and blood levels of vascular endothelial function and hypersensitive C-reactive protein (hs-CRP) in elderly patients with isolated systolic hypertension (EISH).
  
  
  METHODS
  Adopting randomized, double-blinded and controlled principle, a trial was conducted on 135 patients with EISH by randomized them into three groups, they were administered IMR (Group A), JYC plus ND simulator (Group B) and ND plus JYC simulator (Group C) respectively, for 4 weeks. Changes of blood pressure and TCM symptoms, as well as the levels of serum nitric oxide (NO), plasma endothelin-1 (ET-1), 6-keto-prostaglandin 1alpha (6-keto-PGF(1alpha)), thromboxane B2 (TXB2) and hs-CRP were observed before and after treatment.
  
  
  RESULTS
  After treatment the systolic blood pressure reduced and clinical symptoms improved, with serum NO and 6-keto-PGF(1alpha) lelels elevated, plasma ET-1, TXB2 and serum hs-CRP decreased in all the three groups (P<0.05 or P<0.01). But the inter-group comparisons showed that the effect in Group A was superior to the other two groups in decreasing systolic pressure, and superior to Group C in improving clinical symptoms, elevating serum NO and decreasing plasma TXB2 (P <0.05).
  
  
  CONCLUSIONS
  The integrative medical regimen of combined use JYC and ND has markedly effect in lowering blood pressure, it could obviously improve the symptoms and vascular endothelial function, and inhibit the level of inflammatory factor in patients with EISH.
authors.affiliation: Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing.
authors.forename: Hao
authors.initials: H
authors.lastname: Li
authors.forename: Wen-Ming
authors.initials: WM
authors.lastname: Zhao
authors.forename: Yong-Xiang
authors.initials: YX
authors.lastname: Han
mesh_terms: D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D055048:Integrative Medicine; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000097:blood; D008517:Phytotherapy; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D004365:Drugs, Chinese Herbal; D019332:Endothelin-1; D009569:Nitric Oxide; D013929:Thromboxane B2; D009553:Nimodipine; D002097:C-Reactive Protein